Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 1974 Jan;236(2):483-98.
doi: 10.1113/jphysiol.1974.sp010448.

The effect of lowering the 5-hydroxytryptamine content of the rat spinal cord on analgesia produced by morphine

The effect of lowering the 5-hydroxytryptamine content of the rat spinal cord on analgesia produced by morphine

M Vogt. J Physiol. 1974 Jan.

Abstract

1. Injection of 5,6-dihydroxytryptamine (5,6-DHT, 50 mug) into a lateral cerebral ventricle of male rats lowered the 5-hydroxytryptamine (5-HT) content of the lumbar cord to 12.8% and reduced the analgesic effect of low doses of morphine (0.64-1.63 mg/kg), tested by exerting pressure on the foot; after doses of morphine of 1.33-1.63 mg/kg, the analgesic response was reduced or abolished in 33% of the rats, and after 0.64 mg/kg, 58% of the animals failed to respond normally.2. Two days after an I.P. injection of p-chlorophenylalanine (pCPA, 320 mg/kg), the loss of analgesic potency of morphine was more pronounced than after intraventricular 5,6-HDT. The 5-HT content was lowered to about 8% in the lumbar cord, and to 20% or less in pons and medulla.3. The experiments show that interference with the descending tryptaminergic axons innervating the cord is by itself sufficient to reduce analgesia due to morphine, but they do not exclude the possibility that other tryptaminergic neurones take part in the effect of pCPA. The contribution to the analgesic effect of morphine made by the interaction of tryptaminergic axons with the interneurones ;gating' the afferent impulses in the posterior columns is discussed.

PubMed Disclaimer

Similar articles

Cited by

References

    1. J Pharmacol Exp Ther. 1972 Jul;182(1):155-65 - PubMed
    1. Eur J Pharmacol. 1973 Jun;22(3):311-9 - PubMed
    1. Eur J Pharmacol. 1972 Nov;20(2):171-80 - PubMed
    1. Neuropharmacology. 1973 May;12(5):463-9 - PubMed
    1. J Physiol. 1971 Dec;219(1):103-25 - PubMed

LinkOut - more resources